Glass House Brands Inc. (GLAS): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$105.02M
Year ended 2025-12-31
+17.9%
3-year compound annual growth
2020-12-31: $29.52M2021-12-31: $47.39M2022-12-31: $64.16M2023-12-31: $79.87M2024-12-31: $103.50M2025-12-31: $105.02M$105.02M
2020-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$105.02M+1.5%2026-03-24, From 2025-01-01
2024-12-31$103.50M+29.6%2026-03-24, From 2024-01-01
2023-12-31$79.87M+24.5%2025-03-25, From 2023-01-01
2022-12-31$64.16M+35.4%2024-04-02, From 2022-01-01
2021-12-31$47.39Mn/c2024-04-02, From 2021-01-01
2020-12-31$29.52Mn/a2022-04-01, From 2020-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Glass House Brands Inc. (GLAS)2025-12-31$105.02M+1.5%
Marimed Inc. (MRMD)2025-12-31$101.94M+7.2%
Natural Alternatives International Inc (NAII)2026-06-30$133.52M+10.7%
Niagen Bioscience, Inc. (NAGE)2025-12-31$46.23M+21.6%
Jushi Holdings Inc. (JUSH)2025-12-31$148.93M+7.0%
Mannatech Inc (MTEX)2025-12-31$27.08M+2.5%
Fitlife Brands, Inc. (FTLF)2025-12-31$50.01M+37.4%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$330.90M-12.3%
Cresco Labs Inc. (CRLBF)2025-12-31$331.28M-7.9%

Compare GLAS, MRMD, NAII, NAGE side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗